company

DISEN PHARMA HOLDING AS

0382 OSLO

Return on Equity
−264,59 %
Current Ratio
3,96
Debt-to-Equity Ratio
0,18
Key figures (NOK)2022
Revenue455 000
Net Income−1 868 000
Total Assets1 110 000
Total Equity706 000
Income (NOK)2022
Revenue455 000
Expenditure1 242 000
Operating Profit−787 000
Financial Income1 164 000
Financial Costs2 244 000
Financial Balance−1 080 000
Earnings Before Tax−1 868 000
Tax0
Net Income−1 868 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets1 110 000
Total Assets1 110 000
Total Retained Equity606 000
Total Equity706 000
Total Long-Term Debt125 000
Total Current Debt280 000
Total Equity and Debt1 110 000
Cash flow (NOK)2022
Sales Income455 000
Other Income0
Revenue455 000
Cost of Goods Sold0
Salary Costs1 193 000
Depreciation0
Impairment0
Expenditure1 242 000
Operating Profit−787 000
Financial Income1 164 000
Financial Costs2 244 000
Financial Balance−1 080 000
Dividends0
Net Income−1 868 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments877 000
Cash, Bank158 000
Total Current Assets1 110 000
Total Assets1 110 000
Total Equity706 000
Short-Term Group Debt0
Total Long-Term Debt125 000
Creditors7 000
Unpaid Taxes147 000
Dividends0
Other Current Debt126 000
Total Current Debt280 000
Total Equity and Debt1 110 000
Financial indicators2022
Return on Equity−264,59 %
Debt-to-Equity Ratio0,18
Operating Profit Margin−172,97 %
Current Ratio3,96
Quick Ratio3,96
Equity Ratio0,64
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English